Poly Medicure Ltd
NSE:POLYMED

Watchlist Manager
Poly Medicure Ltd Logo
Poly Medicure Ltd
NSE:POLYMED
Watchlist
Price: 1 298.3 INR 3.36% Market Closed
Market Cap: ₹131.6B

Gross Margin

68.2%
Current
Improving
by 4.6%
vs 3-y average of 63.6%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
68.2%
=
Gross Profit
₹12.2B
/
Revenue
₹17.8B

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
68.2%
=
Gross Profit
₹12.2B
/
Revenue
₹17.8B

Peer Comparison

Country Company Market Cap Gross
Margin
IN
Poly Medicure Ltd
NSE:POLYMED
131.6B INR
Loading...
US
Medline Inc
NASDAQ:MDLN
63.4B USD
Loading...
JP
Hoya Corp
TSE:7741
9.5T JPY
Loading...
CH
Alcon AG
SIX:ALC
32.4B CHF
Loading...
DK
Coloplast A/S
CSE:COLO B
108.4B DKK
Loading...
US
Align Technology Inc
NASDAQ:ALGN
13.6B USD
Loading...
UK
ConvaTec Group PLC
LSE:CTEC
5B GBP
Loading...
CA
Bausch + Lomb Corp
NYSE:BLCO
6.5B USD
Loading...
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
41.1B CNY
Loading...
JP
Asahi Intecc Co Ltd
TSE:7747
887B JPY
Loading...
US
Lantheus Holdings Inc
NASDAQ:LNTH
4.9B USD
Loading...

Market Distribution

Higher than 82% of companies in India
Percentile
82st
Based on 4 996 companies
82st percentile
68.2%
Low
-3 052.3% — 26.9%
Typical Range
26.9% — 53.3%
High
53.3% — 8 269.1%
Distribution Statistics
India
Min -3 052.3%
30th Percentile 26.9%
Median 39%
70th Percentile 53.3%
Max 8 269.1%

Poly Medicure Ltd
Glance View

Poly Medicure Ltd., an Indian manufacturer of medical devices, is a compelling narrative of innovation driving tangible impact in healthcare. It embarked on its journey in the late 1990s, seizing on the escalating demand for high-quality medical consumables. The company carved its niche by producing a wide array of disposable medical devices like catheters, infusion therapy systems, and wound closure products, essential in medical facilities worldwide. By establishing a robust manufacturing infrastructure and leveraging economies of scale, Poly Medicure ensures competitive pricing while adhering to global quality standards. A dedication to research and development undergirds their operation, constantly pushing the envelope of modern medical technology. Revenue streams flow primarily from the sale of these innovative products to hospitals, healthcare institutions, and distributors across more than 100 countries. The company's strategic positioning in the industry is further reinforced by its commitment to sustainability and stringent adherence to regulatory compliance, which helps in sustaining long-term contracts and partnerships. The expansion of its product range and the adoption of automated manufacturing processes don't just meet but often forecast sector demands. By keeping its pulse on global health trends, Poly Medicure ensures not only stable growth in its financial graphs but also cements its authority as a cornerstone entity in the medical supplies marketplace.

POLYMED Intrinsic Value
HIDDEN
Show
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
68.2%
=
Gross Profit
₹12.2B
/
Revenue
₹17.8B
What is Poly Medicure Ltd's current Gross Margin?

The current Gross Margin for Poly Medicure Ltd is 68.2%, which is above its 3-year median of 63.6%.

How has Gross Margin changed over time?

Over the last 3 years, Poly Medicure Ltd’s Gross Margin has increased from 62.2% to 68.2%. During this period, it reached a low of 54.3% on Mar 31, 2023 and a high of 68.2% on Jan 1, 2026.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett